Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) have earned an average rating of “Moderate Buy” from the eighteen research firms that are currently covering the firm, Marketbeat reports. Nine analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $80.2105.
A number of analysts recently commented on the stock. Jefferies Financial Group decreased their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a report on Wednesday, April 29th. Wells Fargo & Company decreased their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Piper Sandler decreased their price objective on shares of GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Finally, Barclays decreased their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th.
Read Our Latest Stock Report on GE HealthCare Technologies
GE HealthCare Technologies Stock Down 2.4%
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts predict that GE HealthCare Technologies will post 4.89 earnings per share for the current year.
Insider Activity
In related news, Director Kevin Lobo acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the acquisition, the director owned 14,363 shares in the company, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Peter J. Arduini acquired 4,169 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were bought at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This represents a 1.63% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought 21,847 shares of company stock valued at $1,361,355 in the last quarter. Insiders own 0.36% of the company’s stock.
Hedge Funds Weigh In On GE HealthCare Technologies
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in GE HealthCare Technologies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after acquiring an additional 267,058 shares during the last quarter. Auto Owners Insurance Co raised its position in GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after acquiring an additional 33,629,559 shares during the last quarter. Dodge & Cox raised its position in GE HealthCare Technologies by 13.4% during the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after acquiring an additional 3,693,918 shares during the last quarter. Capital Research Global Investors raised its position in GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after acquiring an additional 389,796 shares during the last quarter. Finally, State Street Corp raised its position in GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after acquiring an additional 401,932 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Read More
- Five stocks we like better than GE HealthCare Technologies
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
